← All stocks

Apyx Medical Corp

APYX Net buying

CIK 0000719135 #4192 in the set updated 21 Sep 2026

Bought (120 mo)

$253.27K

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$113.40K

$0.00 on a plan · $113.40K straight out of an exercise

Sold at will

$0.00

0 of 1 sales

Net

+$139.87K

+$253.27K against sales at will

By person

9 insiders · 27 transactions

0.2×

Charles D. Goodwin holds only 0.2 times base salary in stock. $101.70K of shares against $501.80K in salary for 2025.

Salary from the company's own proxy. The shares are what Charles D. Goodwin last reported holding, valued at $1.13, the price Common Stock was last bought or sold at on the open market here, on 13 Aug 2024.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Goodwin Charles D. II

Chief Executive Officer

$241.76K (4)

—

+$241.76K

90,000

0.2137%

$101.70K

—

Hornsby Todd

Executive Vice President

—

$113.40K (1) scheduled

−$113.40K

<0.0001%

$45.20

0.0%

HILL MATTHEW C

Chief Financial Officer

$11.50K (2)

—

+$11.50K

7,836

0.0186%

$8.85K

—

MAKRIDES ANDREW

Director

—

624,389

1.48%

$705.56K

+1.7%

CITRONOWICZ MOSHE

Sr. V.P. of Operations

—

493,504

1.17%

$557.66K

+15.7%

Waldman Lawrence

Director

—

49,877

0.1184%

$56.36K

—

Geraghty Michael

Director

—

27,500

0.0653%

$31.07K

—

Swandal Craig A.

Director

—

17,000

0.0404%

$19.21K

—

Roman Shawn David

Chief Operating Officer

—

16,467

0.0391%

$18.61K

—

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 125

Amendments (4/A) skipped 2

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 1

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 766,714

History held since 27 Sep 2017